Upregulated GPCRs that have been proposed as therapeutic targets in cancer included the adenosine receptors ADORA1 and ADORA3, and important GPCRs for autocrine growth factors in cancer, such as bombesin receptor NMBR, and neurotensin receptor NTSR145,46. This evidence concerns the gene ADORA1 and cancer.